You are here

Home » Content

Hemodiyalize giren ve girmeyen kronik böbrek yetmezliği olan hastalarda lipit profilleri

Lipid profiles in hemodialysis and nonhemodialysis patients with chronic renal insufficiency

Journal Name:

  • İnönü Üniversitesi Tıp Fakültesi Dergisi

Publication Year:

  • 1994

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
In this study, plasma concentrations of total cholesterol (TC), triglycerides (TG), high density lipoprotein cholesterol (FfDL-C), low density li/xtprotein cholesterol (LDL-C). apolipoprotein A-I (Apo A-l) and B (Apo B). and the ratios of HDL-C to TC, HDL-C to LDL-C and Apo A-I to Apo B in 38 hemodialysis and 30 predialysis patients were compared with the concentrations and ratios in 34 healthy subjects.The highest plasma TC. HDL-C TC . HDL-C/ LDL-C, and Apo A-T Apo B ratios in both of the patient gruops. As a result, these data show that patients who undergo regular hemodialysis show tendency of atherosclerotic disease development. [Journal of Turgut (hal Medical Center 1(3): 194-197,1994]
Bookmark/Search this post with
Abstract (Original Language): 
Bu çalışmada, 38 hemodiyaliz ve 30 prediyaliz hastasında plazma total kolesterol (TC), trigliseritler (TG), yüksek dansiteli lipoprotein kolesterol (HDL-C), düşük dansiteli lipoprotein kolesterol (LDL-C), apolipoprotein A-l (Apo A-I), apolipoprotein B (Apo B) konsantrasyonları ile HDL-C"nin TC'ye, HDL-C nin LDL-C ye ve Apo A-I 'in Apo B 'ye olan oranları 34 sağlıklı kişinin plazma konsantrasyonları ve oranları ile karşılaştırıldı. Hemodiyaliz hastalarında plazma TC, HDL-C ve Apo A-l daha düşük ancak plazma TG 'i daha yüksek olarak tespit edildi. Kontrollerle karşılaştırılınca HDL-C TC. HDL-C/LDL-C ve Apo A-I/Apo B oranlarının her iki hasta grubunda da anlamlı farklılık vardı. Sonuç olarak, bu verilere göre düzenli hemodiyalize giren hastalarda aterosklerotik hastalık gelişme riski vardır. {Turgut Özal Tıp Merkezi Dergisi 1(3): 194-İT. 1994]
FULL TEXT (PDF): 
PDF icon arastirmax-hemodiyalize-giren-girmeyen-kronik-bobrek-yetmezligi-olan-hastalarda-lipit-profilleri.pdf
  • 3
194-197
  • Turkish

REFERENCES

References: 

1 .Attman PO, Gustafson A. Lipid and carbonhydrate metabolism in uremia. Eur J Clin Invest 1979; 9: 285-91.
2 Brunner FP, Broyer M, et al. Survival on renal replacement therapy: Data form the EDTA registry. Nephrol Dial Transplant 1988; 2: 109-22.
3Nestel PJ, Fidge NH, Tan MR Increased
lipoprotein remnant formation in chronic renal
failure. N Eng J Med 1982; 307-29.
4Alsayed N, Rebourcekt R. Abnormal concentrations
of C-II, C-II I and E apolipoproteins among
apolipoprotein B containing, B-free, and A-I
containing lipoprotein particles in hemodialysis
patients. Clin Chem 1991; 37: 387-93.
5.Appel G. Lipid abnormalities in renal diseases.
Kidney Int 1991; 39: 169-83.
ö.Attman
PO
, Aloupovic P. Lipid abnormalities in chronic renal insufficiency. Kidney Int 1991; 39: 16¬23.
7 Avram MM, Fein PA, Antignani A, et al. Cholesterol and lipid disturbances in renal disease: The natural history of uremic dislipidemia and the impact of hemodialysis and continuous ambulatory peritoneal dialysis. Am J Med 1989; 87: 55-60.
8 Cachera A, Kandoussi A, Equagoo K, et al. Evaluation of apolipoprotein A-I containing particles in chronic renal failure patients undergoing hemodialysis. Am J Nefrol 1990; 10: 171-2.
9. Kaysen GA. Hiperlipidemia of the nephrotic syndrome. Kidney Int 1991; 39: 8-15.
10. Keane WF, Mulcahy WS, Kasiske BL, et al. Hiperlipidemia and progessive renal disease. Kidney Int 1991; 39: 41-8.
11. Macieski JJ, Holmes DR, Kottke BA. Apolipoprotein A-I as a marker of angiographically assessed coronary artery disease. N Eng J Med 1989; 309. 385-9.
12 Rom PA, Green CA, Reagan KA, Rackley CE. Relation of serum lipoprotein cholesterol levels to presence and severity of angiographic coronary artery disease. Am J Cardiol 1991; 67: 479-83.
13 Freedman DS, Snlivasan SR, Shear CL, et al. The relation of apolipoproteins A-I and B in children to parenteral myocardial infarction. N Eng J Med
Journal of Turgut Özal Medical Center 1(3): 1994
196
Akçay et al.
Lipid profiles in hemodialysis and nonhemodialysis patients with chronic renal insufficiency
1986; 315: 721-26.
14.Alsayed N and Rebourcet R. Abnormal concentrations of C-II, C-III, and E apolipoprotein B-containing lipoprotein particles in hemodialysis patients Clin Chem 1991; 37: 387-93. 15Tschope W , Koch M , Thomas B , Ritz E and the Germany Study Group. Diabetes and uremia: Serum lipids predict cardiac death in diabetic patients on maintenance hemodialysis. Nephro 1993; 64: 354-8. 16 Parsy D, Dranco M, Cacrera C, Parra HJ,
Vanhoutte G, et al. Lipoprotein abnormalities in chronic hemodialysis patients. Nephrol Dial Transplant 1988; 3: 51-6.
17.The Bezafibrate Infarction Prevention Study Group, Israel. Distribution of C-II and C-III peptides in lipoprotein classes: Methods and clinical significance. Clin Che 1994; 40: 240-4. 18 The Bezafibrate Infarction Prevention Study Group, Israel. Lipids and lipoproteins in symptomatic coronary heart disesase. Circulation 1992,86.839-48.

Thank you for copying data from http://www.arastirmax.com